Tax Exempt Identification Number: 04-3265830
Dyax Corp. Makes Christmas Special
Donation to Methuen Arlington Neighborhood
METHUEN – The Methuen Arlington Neighborhood, Inc., each year has a program for the children of our neighborhood called “Adopt-a-Child,” which provides toys, clothing, food and so much more in the spirit of the holidays to children in need. Providing 298 children with presents for Christmas takes coordination, generosity of individuals, commitment from many and, most of all, the love and caring of other human beings! It also takes donations of toys, food, clothing, coats and so much more. It is a special feeling when you know that you are helping a family enjoy their holidays as you enjoy yours. This year we would like to highlight the generosity of Dyax Corp.
Dyax, due to the generous spirit of the Company and its employees, participated in last year’s program by “adopting” 51 children for the holiday. This year, Dyax “adopted” 88 children, increasing their support of this vital community initiative and helping to make the holiday season a joyous one for many families. “We are so grateful for the support of Dyax,” said Linda Soucy of the Methuen Arlington Neighborhood. “Their generosity has allowed us to grow this program that supports families, and especially children, during this holiday season,” said Soucy.
“We are delighted to participate in a program designed to make the holiday season a special one for children in need,” said Gustav Christensen, President and Chief Executive Officer of Dyax. “Dyax believes strongly in giving back to our communities, and participation in this program is reflective of our values.”
Dyax is a fully integrated biopharmaceutical company focused on the development and commercialization of novel biotherapeutics for unmet medical needs. The Company currently markets KALBITOR® (ecallantide) for the treatment of acute attacks of HAE and is developing DX-2930, a fully human monoclonal antibody, for the potential prophylactic treatment of HAE. Additionally, Dyax has broadly licensed its phage display technology and has a portfolio of product candidates being developed by multiple licensees that it refers to as the Licensing and Funded Research Portfolio.
For additional information about Dyax, please visit www.dyax.com.
For additional information about KALBITOR, including full prescribing information, please visit www.KALBITOR.com.
About Methuen Arlington Neighborhood, Inc. : The mission of M.A.N., Inc. is to increase and enhance entrepreneurial opportunities, neighborhood investment, revitalization activities, and self-sufficiency of low and moderate income residents of the Methuen Arlington Neighborhood. Main focus areas include: Public Safety, youth programs, affordable housing, social services, transportation, employment, and child care. To learn more about M.A.N., Inc., please visit www.methuenarlington.com.